Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers
Molecular Cell · 2024
DOI: 10.1016/j.molcel.2024.04.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2024. Verfasst von Chao Mao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: m_c@fox…. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Electron Transport Complex I, Ferroptosis. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
The role of the mitochondrial electron transport chain (ETC) in regulating ferroptosis is not fully elucidated. Here, we reveal that pharmacological inhibition of the ETC complex I reduces ubiquinol levels while decreasing ATP levels and activating AMP-activated protein kinase (AMPK), the two effects known for their roles in promoting and suppressing ferroptosis, respectively. Consequently, the impact of complex I inhibitors on ferroptosis induced by glutathione peroxidase 4 (GPX4) inhibition is limited. The pharmacological inhibition of complex I in LKB1-AMPK-inactivated cells, or genetic ablation of complex I (which does not trigger apparent AMPK activation), abrogates the AMPK-mediated ferroptosis-suppressive effect and sensitizes cancer cells to GPX4-inactivation-induced ferroptosis. Furthermore, complex I inhibition synergizes with radiotherapy (RT) to selectively suppress the growth of LKB1-deficient tumors by inducing ferroptosis in mouse models. Our data demonstrate a multifaceted role of complex I in regulating ferroptosis and propose a ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: m_c@foxmail.com.
- Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
- Kadmon Corporation, LLC (A Sanofi Company), New York, NY 10016, USA.
- Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Translational Research to AdvanCe Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Mao, C., Lei, G., Horbath, A., Wang, M., Lu, Z., Yan, Y., Liu, X., Kondiparthi, L., Chen, X., Cheng, J., Li, Q., Xu, Z., Zhuang, L., Fang, B., Marszalek, J. R., Poyurovsky, M. V., Olszewski, K., & Gan, B. (2024). Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers. Molecular Cell. https://doi.org/10.1016/j.molcel.2024.04.009
Vancouver
Mao C, Lei G, Horbath A, Wang M, Lu Z, Yan Y, et al. Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers. Molecular Cell. 2024. doi:10.1016/j.molcel.2024.04.009
BibTeX
@article{Mao2024,
author = {Mao, Chao and Lei, Guang and Horbath, Amber and Wang, Min and Lu, Zhengze and Yan, Yuelong and Liu, Xiaoguang and Kondiparthi, Lavanya and Chen, Xiong and Cheng, Jun and Li, Qidong and Xu, Zhihao and Zhuang, Li and Fang, Bingliang and Marszalek, Joseph R and Poyurovsky, Masha V and Olszewski, Kellen and Gan, Boyi},
title = {Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers},
journal = {Molecular Cell},
year = {2024},
doi = {10.1016/j.molcel.2024.04.009}
}
EUVIMED